Norris Medicines

{
  "main_header": {
    "sid": 210607,
    "name": "Norris Medicines",
    "stock_name": "Norris Medicines",
    "full_name": "Norris Medicines Ltd",
    "name_url": "stocks-analysis/norris-medicines",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "12.75",
    "chg": -0.92,
    "chgp": "-6.73%",
    "dir": -1,
    "prev_price": "13.67",
    "mcapval": "13.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524414,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE744C01029",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": "822 ",
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/norris-medicines-210607-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Norris Medicines Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3800204",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NorrisMedicines_priceRelatedfactors_3800204.png",
        "date": "2026-01-22 11:16:24",
        "description": "Norris Medicines Ltd, a company operating in the Trading & Distributors sector, recorded a new 52-week low of Rs.12.5 today, marking a significant milestone in its ongoing price decline. This fresh low comes after a sustained period of underperformance relative to both its sector and the broader market indices."
      },
      {
        "title": "Norris Medicines Ltd Stock Falls to 52-Week Low of Rs.12.87",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-falls-to-52-week-low-of-rs1287-3798479",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NorrisMedicines_priceRelatedfactors_3798479.png",
        "date": "2026-01-21 11:11:54",
        "description": "Norris Medicines Ltd’s shares declined sharply to a fresh 52-week low of Rs.12.87 on 21 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial and market performance."
      },
      {
        "title": "Norris Medicines Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3796717",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NorrisMedicines_priceRelatedfactors_3796717.png",
        "date": "2026-01-20 15:12:02",
        "description": "Norris Medicines Ltd touched a fresh 52-week low of Rs.13.5 today, marking a significant decline in its share price amid a sustained downward trend. The stock has underperformed both its sector and the broader market, reflecting ongoing pressures on the company’s financial and market metrics."
      },
      {
        "title": "Norris Medicines Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/norris-medicines-ltd-is-rated-strong-sell-3771207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NorrisMedicines_mojoScore_3771207.png",
        "date": "2025-12-26 15:12:32",
        "description": "Norris Medicines Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Norris Medicines Sees Revision in Market Evaluation Amid Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/norris-medicines-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-outlook-3753298",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NorrisMedicines_mojoScore_3753298.png",
        "date": "2025-12-09 10:10:19",
        "description": "Norris Medicines has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that highlight ongoing challenges in its financial and operational performance. The changes in assessment metrics underscore the company’s current position within the Trading & Distributors sector and its microcap status."
      },
      {
        "title": "Norris Medicines Stock Falls to 52-Week Low of Rs.14 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-stock-hits-52-week-low-amidst-continued-downtrend-3746772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NorrisMedicines_priceRelatedfactors_3746772.png",
        "date": "2025-12-04 12:42:02",
        "description": "Norris Medicines has reached a new 52-week low of Rs.14, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial and market position."
      },
      {
        "title": "Norris Medicines Stock Falls to 52-Week Low of Rs.14.02 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-stock-falls-to-52-week-low-of-rs1402-amidst-weak-fundamentals-3743429",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NorrisMedicines_priceRelatedfactors_3743429.png",
        "date": "2025-12-03 09:53:21",
        "description": "Norris Medicines has reached a new 52-week low of Rs.14.02, marking a significant decline in its stock price amid broader market fluctuations and sector underperformance. The stock's recent movement reflects ongoing challenges within the company’s financial metrics and market positioning."
      },
      {
        "title": "Norris Medicines Stock Hits 52-Week Low at Rs.14.02 Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-stock-hits-52-week-low-amidst-weak-financial-metrics-3743427",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NorrisMedicines_priceRelatedfactors_3743427.png",
        "date": "2025-12-03 09:53:09",
        "description": "Norris Medicines has reached a new 52-week low of Rs.14.02, marking a significant decline in its stock price amid broader market fluctuations and sector underperformance. The stock's current trading levels reflect ongoing pressures within the Trading & Distributors sector, contrasting with the broader market's relative strength."
      },
      {
        "title": "Norris Medicines Stock Falls to 52-Week Low of Rs.14.5 Amidst Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-stock-falls-to-52-week-low-of-rs145-amidst-weak-financial-metrics-3738366",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NorrisMedicines_priceRelatedfactors_3738366.png",
        "date": "2025-12-01 11:12:06",
        "description": "Norris Medicines has reached a new 52-week low of Rs.14.5 today, marking a significant decline in its stock price amid continued underperformance relative to its sector and broader market indices."
      }
    ],
    "total": 249,
    "sid": "210607",
    "stock_news_url": "https://www.marketsmojo.com/news/norris-medicines-210607"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "As per attachment.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "As per attachment.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Completion Of NAFDAC Audit (Nigeria) Of Norris Medicines Limited.",
      "datetime": "12-Dec-2025",
      "details": "As per attachment.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Norris Medicines Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-01-22 11:16:24

Norris Medicines Ltd, a company operating in the Trading & Distributors sector, recorded a new 52-week low of Rs.12.5 today, marking a significant milestone in its ongoing price decline. This fresh low comes after a sustained period of underperformance relative to both its sector and the broader market indices.

Read full news article

Norris Medicines Ltd Stock Falls to 52-Week Low of Rs.12.87

2026-01-21 11:11:54

Norris Medicines Ltd’s shares declined sharply to a fresh 52-week low of Rs.12.87 on 21 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial and market performance.

Read full news article

Norris Medicines Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-01-20 15:12:02

Norris Medicines Ltd touched a fresh 52-week low of Rs.13.5 today, marking a significant decline in its share price amid a sustained downward trend. The stock has underperformed both its sector and the broader market, reflecting ongoing pressures on the company’s financial and market metrics.

Read full news article

Norris Medicines Ltd is Rated Strong Sell

2025-12-26 15:12:32

Norris Medicines Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 June 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Norris Medicines Sees Revision in Market Evaluation Amid Challenging Financial Trends

2025-12-09 10:10:19

Norris Medicines has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that highlight ongoing challenges in its financial and operational performance. The changes in assessment metrics underscore the company’s current position within the Trading & Distributors sector and its microcap status.

Read full news article

Norris Medicines Stock Falls to 52-Week Low of Rs.14 Amidst Prolonged Downtrend

2025-12-04 12:42:02

Norris Medicines has reached a new 52-week low of Rs.14, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial and market position.

Read full news article

Norris Medicines Stock Falls to 52-Week Low of Rs.14.02 Amidst Market Pressure

2025-12-03 09:53:21

Norris Medicines has reached a new 52-week low of Rs.14.02, marking a significant decline in its stock price amid broader market fluctuations and sector underperformance. The stock's recent movement reflects ongoing challenges within the company’s financial metrics and market positioning.

Read full news article

Norris Medicines Stock Hits 52-Week Low at Rs.14.02 Amid Market Pressure

2025-12-03 09:53:09

Norris Medicines has reached a new 52-week low of Rs.14.02, marking a significant decline in its stock price amid broader market fluctuations and sector underperformance. The stock's current trading levels reflect ongoing pressures within the Trading & Distributors sector, contrasting with the broader market's relative strength.

Read full news article

Norris Medicines Stock Falls to 52-Week Low of Rs.14.5 Amidst Underperformance

2025-12-01 11:12:06

Norris Medicines has reached a new 52-week low of Rs.14.5 today, marking a significant decline in its stock price amid continued underperformance relative to its sector and broader market indices.

Read full news article

View All News